Vertex and CRISPR Therapeutics have won the backing of NICE for their gene-editing therapy Casgevy as a treatment for the blood disorder beta thalassaemia, a few months after turning it down for ...
It's estimated about 1.2 million people die around the world each year from drug resistant infections, with the number predicted to balloon to 10m by 2050. Known scientifically as anti-microbial ...
Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of ...